DELCATH SYSTEMS
DCTH Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-06-12
2025-06-13
VUKOVIC VOJO
CHIEF MEDICAL OFFICER
M - Exercise
Common Stock
42,000
$5.00
210K
1
$493.14M
2025-06-12
2025-06-13
VUKOVIC VOJO
CHIEF MEDICAL OFFICER
M - Exercise
Employee Stock Option (Right to Buy)
-42,000
$0.00
1
$493.14M
2025-05-15
2025-05-19
SYLVESTER JOHN RICHARD
A - Grant
Stock Option (right to buy)
22,500
$0.00
1
$493.14M
2025-02-07
2025-02-07
MICHEL GERARD
CHIEF EXECUTIVE OFFICER
A - Grant
Stock Option (Right to Buy)
390K
$0.00
1
$493.14M
2025-02-07
2025-02-07
HOFFMAN DAVID
GEN'L COUNSEL, CCO & SECY
A - Grant
Stock Option (Right to Buy)
113K
$0.00
1
$493.14M
2025-02-07
2025-02-07
MUIR KEVIN
GM INTERVENTIONAL ONCOLOGY
A - Grant
Stock Option (Right to Buy)
113K
$0.00
1
$493.14M
2025-02-07
2025-02-07
PENNELL SANDRA
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
113K
$0.00
1
$493.14M
2025-02-07
2025-02-07
ROOK MARTHA
CHIEF OPERATING OFFICER
A - Grant
Stock Option (Right to Buy)
113K
$0.00
1
$493.14M
2025-02-07
2025-02-07
VUKOVIC VOJO
CHIEF MEDICAL OFFICER
A - Grant
Stock Option (Right to Buy)
113K
$0.00
1
$493.14M
2024-12-24
2024-12-26
ROSALIND ADVISORS, INC.
M - Exercise
Pre-funded Warrants
604K
$10.00
6.04M
1
$493.14M
2024-10-30
2024-11-01
AHARON GIL
M - Exercise
Tranche B warrants to purchase F-4 Preferred Stock
500
$1,000.00
500K
1
$493.14M
2024-10-30
2024-11-01
ROSALIND ADVISORS, INC.
M - Exercise
Tranche B warrants to purchase F-4 Preferred Stock
500
$1,000.00
500K
1
$493.14M
2024-10-30
2024-11-01
SALAMON STEVEN
M - Exercise
Tranche B warrants to purchase F-4 Preferred Stock
500
$1,000.00
500K
1
$493.14M
2024-10-22
2024-10-23
MICHEL GERARD
CHIEF EXECUTIVE OFFICER
M - Exercise
Tranche B Warrants to Purchase Common Stock
-16,666
$0.00
1
$493.14M
2024-10-22
2024-10-23
MICHEL GERARD
CHIEF EXECUTIVE OFFICER
M - Exercise
Common Stock
16,666
$6.00
99,996
1
$493.14M
2024-05-23
2024-05-28
SYLVESTER JOHN RICHARD
A - Grant
Stock Option (right to buy)
22,500
$0.00
1
$493.14M
2024-05-23
2024-05-28
STOLL ROGER PHD
D - Sale to Issuer
Stock Option (Right to Buy)
-77,824
$0.00
5
$493.14M
2024-03-19
2024-03-20
ROSALIND ADVISORS, INC.
P - Purchase
Pre-funded Warrants
620K
$4.00
2.48M
1
$493.14M
2024-03-18
2024-03-20
ROOK MARTHA
CHIEF OPERATING OFFICER
A - Grant
Employee Stock Option (Right to Buy)
125K
$0.00
1
$493.14M
2024-03-19
2024-03-19
VUKOVIC VOJO
CHIEF MEDICAL OFFICER
A - Grant
Common Stock
26,882
$4.00
108K
1
$493.14M
2024-03-19
2024-03-19
MICHEL GERARD
CHIEF EXECUTIVE OFFICER
A - Grant
Common Stock
40,323
$4.00
161K
1
$493.14M
2024-03-19
2024-03-19
HOFFMAN DAVID
GEN'L COUNSEL, CCO & SECY
A - Grant
Common Stock
20,161
$4.00
80,644
1
$493.14M
2024-03-19
2024-03-19
MUIR KEVIN
GM INTERVENTIONAL ONCOLOGY
A - Grant
Common Stock
13,441
$4.00
53,764
1
$493.14M
2024-03-19
2024-03-19
PENNELL SANDRA
SVP OF FINANCE, PFO AND PAO
A - Grant
Common Stock
26,881
$4.00
108K
1
$493.14M
2023-02-08
2024-02-20
DIAS ANTHONY
VP FINANCE
A - Grant
Stock Option (Right to Buy)
31,200
$0.00
1
$493.14M
2024-02-12
2024-02-14
MUIR KEVIN
VP COMMERCIAL OPERATIONS
A - Grant
Stock Option (Right to Buy)
101K
$0.00
1
$493.14M
2024-02-12
2024-02-14
HOFFMAN DAVID
GEN'L COUNSEL, CCO & SECY
A - Grant
Stock Option (Right to Buy)
101K
$0.00
1
$493.14M
2024-02-12
2024-02-14
MICHEL GERARD
CHIEF EXECUTIVE OFFICER
A - Grant
Stock Option (Right to Buy)
302K
$0.00
1
$493.14M
2024-02-12
2024-02-14
PENNELL SANDRA
SVP OF FINANCE, PFO AND PAO
A - Grant
Stock Option (Right to Buy)
101K
$0.00
1
$493.14M
2024-02-12
2024-02-14
VUKOVIC VOJO
CHIEF MEDICAL OFFICER
A - Grant
Stock Option (Right to Buy)
101K
$0.00
1
$493.14M
2023-02-08
2024-01-26
HOFFMAN DAVID
GEN'L COUNSEL, CCO & SECY
A - Grant
Stock Option (Right to Buy)
46,800
$0.00
1
$493.14M
2023-02-08
2024-01-26
JOHN JOHNNY
SVP CLINICAL DEV & MED AFFAIRS
A - Grant
Stock Option (Right to Buy)
46,800
$0.00
1
$493.14M
2023-02-08
2024-01-26
MICHEL GERARD
CHIEF EXECUTIVE OFFICER
A - Grant
Stock Option (Right to Buy)
140K
$0.00
1
$493.14M
2023-02-08
2024-01-26
MUIR KEVIN
VP COMMERCIAL OPERATIONS
A - Grant
Stock Option (Right to Buy)
46,800
$0.00
1
$493.14M
2023-02-08
2024-01-26
PURPURA JOHN
CHIEF OPERATING OFFICER
A - Grant
Stock Option (Right to Buy)
56,160
$0.00
1
$493.14M
2023-12-12
2023-12-14
VUKOVIC VOJO
Chief Medical Officer
P - Purchase
Common Stock
40,000
$3.00
120K
1
$493.14M
2023-12-08
2023-12-11
MICHEL GERARD
Chief Executive Officer
P - Purchase
Common Stock
34,000
$3.00
102K
1
$493.14M
2023-11-17
2023-11-21
PENNELL SANDRA
SVP of Finance, PFO and PAO
P - Purchase
Common Stock
30,000
$2.00
60,000
1
$493.14M
2023-11-16
2023-11-20
HOFFMAN DAVID
General Counsel, Chief Complia...
P - Purchase
Common Stock
40,000
$2.00
80,000
1
$493.14M
2023-11-16
2023-11-20
VUKOVIC VOJO
Chief Medical Officer
P - Purchase
Common Stock
60,000
$2.00
120K
1
$493.14M
2023-10-13
2023-10-17
PURPURA JOHN
Chief Operating Officer
P - Purchase
Common Stock
14,505
$3.00
43,515
1
$493.14M
2023-08-21
2023-08-22
ROSALIND ADVISORS, INC.
X - Exercise
Tranche A Warrant
3,010
$1,000.00
3.01M
1
$493.14M
2023-08-18
2023-08-21
MICHEL GERARD
Chief Executive Officer
X - Exercise
Tranche A Warrants to Purchase Common Stock
-31,110
$0.00
1
$493.14M
2023-08-18
2023-08-21
MICHEL GERARD
Chief Executive Officer
X - Exercise
Common Stock
31,110
$5.00
156K
1
$493.14M
2023-06-12
2023-06-22
MUIR KEVIN
Vice President Commercial Oper...
A - Grant
Stock Option (Right to Buy)
59,813
$0.00
1
$493.14M
2023-06-12
2023-06-22
PURPURA JOHN
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
59,813
$0.00
1
$493.14M
2023-06-12
2023-06-22
SYLVESTER JOHN RICHARD
A - Grant
Stock Option (Right to Buy)
19,682
$0.00
1
$493.14M
2023-06-12
2023-06-21
HOFFMAN DAVID
General Counsel, Chief Complia...
A - Grant
Stock Option (Right to Buy)
59,813
$0.00
1
$493.14M
2023-06-12
2023-06-21
JOHN JOHNNY
Senior Vice President Clinical...
A - Grant
Stock Option (Right to Buy)
59,813
$0.00
1
$493.14M
2023-06-12
2023-06-21
MICHEL GERARD
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
169K
$0.00
1
$493.14M
2023-06-12
2023-06-21
PENNELL SANDRA
Senior Vice President of Finan...
A - Grant
Stock Option (Right to Buy)
100K
$0.00
1
$493.14M
2023-04-18
2023-04-20
ROSALIND ADVISORS, INC.
H - Expiration/Cancellation
Pre-Funded Warrant
539K
$6.00
3.23M
1
$493.14M
2023-03-29
2023-03-30
MICHEL GERARD
Chief Executive Officer
P - Purchase
Tranche A Warrants to Purchase Common Stock
31,110
$0.00
1
$493.14M
2023-03-29
2023-03-30
MICHEL GERARD
Chief Executive Officer
P - Purchase
Tranche B Warrants to Purchase Common Stock
16,666
$0.00
1
$493.14M
2023-03-29
2023-03-30
MICHEL GERARD
Chief Executive Officer
P - Purchase
Common Stock
19,646
$5.00
98,230
1
$493.14M
2022-12-13
2022-12-14
MICHEL GERARD
Chief Executive Officer
P - Purchase
Common Stock
51,725
$3.00
155K
1
$493.14M
2022-12-13
2022-12-14
ROSALIND ADVISORS, INC.
P - Purchase
Pre-Funded Warrant
692K
$3.00
2.08M
1
$493.14M
2022-07-20
2022-07-21
MICHEL GERARD
Chief Executive Officer
P - Purchase
Common Stock
62,814
$4.00
251K
1
$493.14M
2022-05-16
2022-05-18
PURPURA JOHN
Chief Operating Officer
P - Purchase
Common Stock
3,300
$5.00
16,500
1
$493.14M
2022-05-04
2022-05-06
SYLVESTER JOHN RICHARD
A - Grant
Stock Option (Right to Buy)
9,000
$0.00
1
$493.14M
2022-04-18
2022-04-18
MICHEL GERARD
Chief Executive Officer and In...
P - Purchase
Common Stock
2,000
$6.00
12,000
2
$493.14M
2022-04-11
2022-04-11
PURPURA JOHN
Chief Operating Officer
P - Purchase
Common Stock
5,000
$7.00
35,000
1
$493.14M
2022-04-08
2022-04-08
MICHEL GERARD
Chief Executive Officer and In...
P - Purchase
Common Stock
2,000
$7.00
14,000
2
$493.14M
2020-11-19
2022-04-05
PURPURA JOHN
Chief Operating Officer
P - Purchase
Common Stock
1,600
$13.00
20,800
1
$493.14M
2022-02-08
2022-02-16
PURPURA JOHN
Chief Operating Officer
A - Grant
Employee Stock Option (right to buy)
46,198
$0.00
1
$493.14M
2022-02-08
2022-02-16
MICHEL GERARD
Chief Executive Officer and In...
A - Grant
Employee Stock Option (right to buy)
116K
$0.00
1
$493.14M
2021-08-06
2022-02-14
ROSALIND ADVISORS, INC.
J - Other
Convertible Note Payable
2,000
$1,198.00
2.40M
1
$493.14M
2021-12-02
2021-12-06
MICHEL GERARD
Chief Executive Officer and In...
P - Purchase
Common Stock
23,200
$9.00
209K
1
$493.14M
2021-09-01
2021-10-19
PADULA CHRISTINE
Interim Principal Accounting O...
A - Grant
Employee Stock Option (right to buy)
30,000
$0.00
1
$493.14M
2021-08-05
2021-08-09
MICHEL GERARD
Chief Executive Officer
A - Grant
Employee Stock Option (right to buy)
125K
$0.00
1
$493.14M
2021-08-05
2021-08-09
PURPURA JOHN
Chief Operating Officer
A - Grant
Employee Stock Option (right to buy)
45,000
$0.00
1
$493.14M
2021-08-05
2021-08-09
SYLVESTER JOHN RICHARD
A - Grant
Stock Option (right to buy)
9,000
$0.00
1
$493.14M
2021-06-28
2021-06-29
MICHEL GERARD
Chief Executive Officer
P - Purchase
Common Stock
6,250
$12.00
75,000
1
$493.14M
2021-06-25
2021-06-29
MICHEL GERARD
Chief Executive Officer
P - Purchase
Common Stock
6,600
$11.00
72,600
1
$493.14M
2021-06-24
2021-06-25
AHARON GIL
C - Conversion
Series E-1 Convertible Preferred Stock
-1,122
$0.00
1
$493.14M
2021-06-24
2021-06-25
ROSALIND ADVISORS, INC.
C - Conversion
Series E-1 Convertible Preferred Stock
-1,122
$0.00
1
$493.14M
2021-06-24
2021-06-25
SALAMON STEVEN
C - Conversion
Series E-1 Convertible Preferred Stock
-1,122
$0.00
1
$493.14M
2021-06-23
2021-06-25
ROSALIND ADVISORS, INC.
C - Conversion
Series E Convertible Preferred Stock
-7,561
$0.00
1
$493.14M
2021-06-23
2021-06-25
AHARON GIL
C - Conversion
Series E Convertible Preferred Stock
-7,561
$0.00
1
$493.14M
2021-06-23
2021-06-25
SALAMON STEVEN
C - Conversion
Series E Convertible Preferred Stock
-7,561
$0.00
1
$493.14M
2021-05-13
2021-05-14
PURPURA JOHN
Chief Operating Officer
P - Purchase
Common Stock
4,000
$9.00
36,000
1
$493.14M
2021-04-05
2021-04-05
MICHEL GERARD
Chief Executive Officer
P - Purchase
Common Stock
15,500
$13.00
202K
1
$493.14M
2020-12-11
2020-12-14
MICHEL GERARD
Chief Executive Officer
P - Purchase
Common Stock
7,500
$13.00
97,500
1
$493.14M
2020-11-23
2020-11-25
PADULA CHRISTINE
Interim Principal Accounting O...
A - Grant
Employee Stock Option (right to buy)
20,000
$0.00
1
$493.14M
2020-11-23
2020-11-25
PURPURA JOHN
Chief Operating Officer
A - Grant
Employee Stock Option (right to buy)
175K
$0.00
1
$493.14M
2020-11-23
2020-11-25
SYLVESTER JOHN RICHARD
A - Grant
Stock Option (right to buy)
30,000
$0.00
1
$493.14M
2020-11-19
2020-11-20
PURPURA JOHN
Chief Operating Officer
P - Purchase
Common Stock
1,600
$13.00
20,800
1
$493.14M
2020-10-01
2020-10-05
MICHEL GERARD
Chief Executive Officer
A - Grant
Employee Stock Option (right to buyer)
498K
$0.00
1
$493.14M
2020-05-08
2020-05-08
TAGLIETTI MARCO
C - Conversion
Series E Convertible Preferred Stock
-60
$0.00
1
$493.14M
2020-05-08
2020-05-08
STOLL ROGER PHD
C - Conversion
Series E Convertible Preferred Stock
-93
$0.00
1
$493.14M
2020-05-08
2020-05-08
KECK BARBRA
Chief Financial Officer, Secre...
C - Conversion
Series E Convertible Preferred Stock
-68
$0.00
1
$493.14M
2020-05-08
2020-05-08
KECK BARBRA
Chief Financial Officer, Secre...
C - Conversion
Common Stock
6,800
1
$493.14M
2020-05-08
2020-05-08
PURPURA JOHN
Exec. V.P. , Global Head of Op...
C - Conversion
Series E Convertible Preferred Stock
-65
$0.00
1
$493.14M
2020-05-08
2020-05-08
PURPURA JOHN
Exec. V.P. , Global Head of Op...
C - Conversion
Common Stock
6,500
1
$493.14M
2020-05-08
2020-05-08
RUECKERT WILLIAM DODGE
C - Conversion
Series E Convertible Preferred Stock
-60
$0.00
1
$493.14M
2020-05-08
2020-05-08
SIMPSON JENNIFER
President and CEO
C - Conversion
Series E Convertible Preferred Stock
-147
$0.00
1
$493.14M
2020-05-06
2020-05-08
PURPURA JOHN
Exec. V.P. , Global Head of Op...
A - Grant
Common Stock
6,613
$0.00
1
$493.14M
2020-05-06
2020-05-08
KECK BARBRA
Chief Financial Officer, Secre...
A - Grant
Common Stock
6,040
$0.00
1
$493.14M